Get the Stockscreener App
2.60
1.56%
0.04
Eledon Pharmaceuticals Inc stock is traded at $2.60, with a volume of 715.52K.
It is up +1.56% in the last 24 hours and down -29.92% over the past month.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
See More
Previous Close:
$2.56
Open:
$2.55
24h Volume:
715.52K
Relative Volume:
1.09
Market Cap:
$155.69M
Revenue:
-
Net Income/Loss:
$-40.33M
P/E Ratio:
-1.4525
EPS:
-1.79
Net Cash Flow:
$-39.53M
1W Performance:
-1.14%
1M Performance:
-29.92%
6M Performance:
-39.39%
1Y Performance:
-11.86%
1-Day Range:
$2.55
$2.66
1-Week Range:
$2.51
$2.71
52-Week Range:
$2.375
$5.54
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
Name
Eledon Pharmaceuticals Inc
Sector
Industry
Phone
949-238-8090
Address
19800 MACARTHUR BLVD., IRVINE
Compare ELDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
2.60 | 155.39M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-18-25 | Resumed | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Guggenheim | Buy |
| May-13-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-23-21 | Initiated | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc Stock (ELDN) Latest News
Can Eledon Pharmaceuticals Inc. hit a new high this monthJuly 2025 Earnings & Long-Term Safe Return Strategies - Newser
Pattern Scan Adds Eledon Pharmaceuticals Inc. to WatchlistJuly 2025 Intraday Action & Risk Controlled Swing Alerts - newsyoung.net
Tools to assess Eledon Pharmaceuticals Inc.’s risk profileGold Moves & Safe Capital Investment Plans - Newser
What Fibonacci levels say about Eledon Pharmaceuticals Inc. reboundJobs Report & Accurate Technical Buy Alerts - Newser
Historical volatility pattern of Eledon Pharmaceuticals Inc. visualizedJuly 2025 Drop Watch & Free Weekly Watchlist of Top Performers - Newser
Exit strategy if you’re trapped in Eledon Pharmaceuticals Inc.Market Weekly Review & Verified Swing Trading Watchlist - Newser
Key resistance and support levels for Eledon Pharmaceuticals Inc.2025 EndofYear Setup & Daily Growth Stock Investment Tips - Newser
Multi factor analysis applied to Eledon Pharmaceuticals Inc.Weekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - Newser
Regression analysis insights on Eledon Pharmaceuticals Inc. performanceTrade Ideas & Fast Moving Stock Watchlists - Newser
Eledon Pharmaceuticals Inc. stock trendline breakdownJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - Newser
Published on: 2025-08-20 02:23:43 - Newser
How to monitor Eledon Pharmaceuticals Inc. with trend dashboards2025 Technical Patterns & Long-Term Safe Investment Plans - Newser
How high can Eledon Pharmaceuticals Inc. stock goJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
What institutional flow reveals about Eledon Pharmaceuticals Inc.2025 Market Sentiment & Safe Entry Trade Reports - Newser
Risk vs reward if holding onto Eledon Pharmaceuticals Inc.Share Buyback & Capital Protection Trading Alerts - Newser
What indicators show strength in Eledon Pharmaceuticals Inc.Quarterly Profit Review & Consistent Return Strategy Ideas - Newser
Published on: 2025-08-19 14:15:02 - Newser
Will Eledon Pharmaceuticals Inc. outperform the marketMarket Weekly Review & Long-Term Safe Investment Plans - Newser
Visual analytics tools that track Eledon Pharmaceuticals Inc. performanceJuly 2025 Breakouts & Real-Time Volume Analysis - Newser
Analyzing drawdowns of Eledon Pharmaceuticals Inc. with statistical toolsMarket Risk Summary & Entry Point Confirmation Alerts - Newser
Understanding Eledon Pharmaceuticals Inc.’s price movementPrice Action & Risk Managed Investment Signals - Newser
Eledon Pharmaceuticals Advances in Transplant Trials - TipRanks
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Published on: 2025-08-18 00:27:01 - Newser
Using portfolio simulators with Eledon Pharmaceuticals Inc. included2025 Market Trends & Community Supported Trade Ideas - Newser
Order flow analysis tools used on Eledon Pharmaceuticals Inc.2025 Winners & Losers & High Win Rate Trade Tips - Newser
Can Eledon Pharmaceuticals Inc. rally from current levelsVolume Spike & Comprehensive Market Scan Insights - Newser
Eledon Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveMarket Weekly Review & Momentum Based Trading Ideas - Newser
Why Eledon Pharmaceuticals Inc. is moving todayRisk Management & Risk Managed Trade Strategies - Newser
Detecting price anomalies in Eledon Pharmaceuticals Inc. with AIQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Eledon Pharmaceuticals Inc Stock (ELDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):